NYXHNyxoah
About Nyxoah
Nyxoah (EBR:NYXH), (NASDAQ:NYXH) specializes in developing innovative solutions to address obstructive sleep apnea (OSA). Its signature project surrounds the Genio system, a pioneering therapeutic solution designed to improve the quality of life for people suffering from OSA by tackling the condition's root causes rather than its symptoms. This device stands out for its minimally invasive nature and cutting-edge technology aimed at providing a more comfortable and effective treatment option. Nyxoah's primary objective is to revolutionize the OSA treatment landscape by expanding access to its therapies, with ongoing efforts focused on clinical trials and securing regulatory approvals to bring their solutions to a global audience.
What is NYXH known for?
Snapshot
Public US
Ownership
2009
Year founded
144
Employees
Mont-Saint-Guibert, Belgium
Head office
1 of 2
US Rank
Unknown
Sector
N/A
Sector rank
Loading Map...
Operations
All Locations
Kingdom of Belgium
Products and/or services of Nyxoah
- The Genio system, a hypoglossal nerve stimulation therapy for obstructive sleep apnea, offering a patient-centered, clinically proven solution for significant reduction of apnea events.
- Follow-up services including patient monitoring and personalized treatment adjustments to ensure optimal therapy outcomes with the Genio system.
- Comprehensive training programs for physicians and medical professionals, enhancing the effective implementation and utilization of the Genio therapy in clinical practice.
- Advanced research and development aimed at expanding the indications for the Genio therapy, potentially addressing a wider range of sleep-disordered breathing conditions.
- Partnerships with sleep centers and clinics worldwide to increase access to and adoption of innovative sleep apnea treatments, improving patient quality of life.
- Development of next-generation technologies and devices to enhance sleep apnea treatment efficacy, patient comfort, and user experience.
Nyxoah executive team
- Mr. Robert Taub MBACo-Founder & Chairman
- Mr. Olivier TaelmanCEO & Executive Director
- Mr. John LandryChief Financial Officer
- Mr. Bruno OnkelinxChief Technical Officer
- Pearson DennisInvestor Relations Associate
- Ms. An MoonenGeneral Counsel
- Ms. Maggie McGowanChief HR Officer
- Mr. Loic MoreauPresident of International
- Mr. Remi RenardChief of Staff
- Mr. Jeyakumar SubbaroyanChief Clinical Officer